GE HealthCare receives FDA clearance for Portrait VSM, building on its growing patient monitoring ecosystem

Press releases may be edited for formatting or style | April 29, 2024 Patient Monitors
April 29, 2024 CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor that can provide clinicians with an accurate view of patient vital signs to support timely clinical decisions. As the next evolution of the DINAMAP legacy, Portrait VSM utilizes the SuperSTAT non-invasive blood pressure algorithm to provide precise and accurate measurement readings. Through its wireless connectivity and seamless EMR integration, the portable vital signs monitor was designed with the user workflows in mind, offering customized Early Warning Scores (EWS) and enabling care teams to focus on taking care of their patients by automating routine tasks.

Building on GE HealthCare’s family of Portrait monitoring solutions, Portrait VSM can connect with the latest iteration of the Portrait Mobile wireless and wearable continuous monitoring solution to seamlessly integrate patient data in one unified workflow, while ensuring patient mobility. Through a single click of the barcode scanner, Portrait VSM automatically imports the patient demographic data and a snapshot of the patient’s continuously monitored data - respiratory rate, oxygen saturation and pulse rate - from Portrait Mobile. This workflow streamlines the process of clinical rounding and reduces the steps needed to capture and chart a complete set of vital sign measurements.

A connected workflow and EMR integration can help enable accurate vital sign charting and eliminate the delay from manual data entry to support clinicians in making timely and confident treatment decisions.1,2 The uninterrupted flow of data and continuous measurement of vital signs, enabled by Portrait Mobile, can also help clinicians detect patient decline as it is happening, enabling timely intervention before a patient deteriorates.
DOTmed text ad

Reveal Mobi Pro now available for sale in the US

Reveal Mobi Pro integrates the Reveal 35C detector with SpectralDR technology into a modern mobile X-ray solution. Mobi Pro allows for simultaneous acquisition of conventional & dual-energy images with a single exposure. Contact us for a demo at no cost.

Patients’ vital signs are typically measured by traditional spot check methods every 4-6 hours, which can cause early signs of patient deterioration to be missed. Undetected patient deterioration, particularly post-surgery, can lead to hazardous yet preventable consequences, with 30-day mortality after surgery representing the 3rd leading cause of death globally.3 To optimize patient care, Portrait VSM brings together standard spot check capability with continuous patient monitoring through its connectivity to Portrait Mobile.

You Must Be Logged In To Post A Comment